window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : September 19, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

AI drug discovery

  • Advanced Therapies,Digital & Data,Drug Discovery & Development

    AISB Network expands Federated OpenFold3 initiative with three new pharma contributors

    The AI Structural Biology (AISB) Network, powered by Apheris GmbH, [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Pharmaceuticals and therapeutics

    DaltonTx raises £4 million seed financing to build AI-enabled drug discovery platform

    DaltonTx, a UK-based technology company, has exited stealth mode and [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development

    Lilly launches $1 billion TuneLab AI platform to boost biotech drug discovery

    Eli Lilly and Company has launched TuneLab, a new artificial [...]

    May 5, 2026
  • Advanced Therapies,Digital & Data,Drug Discovery & Development

    Latent Labs unveils AI model Latent-X for instant, lab-validated protein binder design

    No-code platform opens early access to generative binder design with [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development

    Optibrium secures multi-million-pound funding to power global AI drug discovery expansion

    Backing from Shawbrook follows rapid customer growth and positions Optibrium [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Opinion & Events

    Lisata and GATC expand partnership to develop AI-discovered treatment for opioid use disorder

    New alliance targets early 2026 for first-in-human trial of non-opioid [...]

    May 5, 2026
  • Advanced Therapies,Digital & Data,Drug Discovery & Development,Therapeutic Areas

    Game-changing £7.5M prize launches to unlock AI drug targets for ALS

    20 global teams will receive early-stage funding and access to [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    Vivodyne raises $40M to advance human tissue testing as alternative to animal models

    Vivodyne has secured $40 million in Series A funding to [...]

    May 5, 2026
  • Digital & Data,Drug Discovery & Development

    EXCLUSIVE interview: How foundation models are redefining small molecule drug discovery

    As generative AI rapidly evolves, one of its most promising [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business

    Creyon Bio and Lilly collaborate on AI-designed RNA-targeted oligo therapies

    Partnership aims to accelerate development using computational drug design Creyon [...]

    May 5, 2026
Previous34

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • AstraZeneca advances oral COPD drug into Phase 2b trial
    Categories: Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Fuse Diagnostics raises £1M to scale rapid molecular testing platform
    Categories: Biotech & Pharma Business, Manufacturing & Supply Chain, Medical devices, Research & Development
  • Amyl Therapeutics raises €8.25M to advance pan-amyloid neurodegenerative disease platform
    Categories: Central Nervous System, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top